Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.
2.
3.

X-ray diffraction analysis of cytochrome P450 2B4 reconstituted into liposomes.

Miller JP, Herbette LG, White RE.

Biochemistry. 1996 Feb 6;35(5):1466-74.

PMID:
8634277
4.

Single crystal X-ray structures of the two 4-heptadecyl derivatives of (1R,5S)-3,6,8-trioxabicyclo[3.2.1]octane.

Moring J, Duclos RI Jr, Zhang JH, Herbette LG, Xie X, Makriyannis A.

Chem Phys Lipids. 1995 Aug 1;77(1):99-112.

PMID:
7586096
5.

Interaction of the NMDA receptor noncompetitive antagonist MK-801 with model and native membranes.

Moring J, Niego LA, Ganley LM, Trumbore MW, Herbette LG.

Biophys J. 1994 Dec;67(6):2376-86.

6.

Favorable amphiphilicity of nimodipine facilitates its interactions with brain membranes.

Herbette LG, Mason PE, Sweeney KR, Trumbore MW, Mason RP.

Neuropharmacology. 1994 Feb;33(2):241-9.

PMID:
8035910
7.

The molecular basis for lacidipine's unique pharmacokinetics: optimal hydrophobicity results in membrane interactions that may facilitate the treatment of atherosclerosis.

Herbette LG, Mason PE, Gaviraghi G, Tulenko TN, Mason RP.

J Cardiovasc Pharmacol. 1994;23 Suppl 5:S16-25. Review.

PMID:
7609501
8.

X-ray diffraction analysis of brain lipid membrane structure in Alzheimer's disease and beta-amyloid peptide interactions.

Mason RP, Shoemaker WJ, Shajenko L, Herbette LG.

Ann N Y Acad Sci. 1993 Sep 24;695:54-8.

PMID:
8239313
9.

Molecular interaction between lacidipine and biological membranes.

Herbette LG, Gaviraghi G, Tulenko T, Mason RP.

J Hypertens Suppl. 1993 Mar;11(1):S13-9.

PMID:
8387105
10.

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol.

Mason RP, Shoemaker WJ, Shajenko L, Chambers TE, Herbette LG.

Neurobiol Aging. 1992 May-Jun;13(3):413-9.

PMID:
1625771
12.

Can altering serum cholesterol affect neurologic function?

Mason RP, Herbette LG, Silverman DI.

J Mol Cell Cardiol. 1991 Nov;23(11):1339-42. No abstract available.

PMID:
1803025
13.

New approaches to drug design and delivery based on drug-membrane interactions.

Herbette LG, Rhodes DG, Mason RP.

Drug Des Deliv. 1991 Apr;7(2):75-118. Review.

PMID:
1910441
14.

Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes.

Mason RP, Rhodes DG, Herbette LG.

J Med Chem. 1991 Mar;34(3):869-77. Review. No abstract available.

PMID:
2002467
15.

Large-scale structural changes in the sarcoplasmic reticulum ATPase appear essential for calcium transport.

Blasie JK, Pascolini D, Asturias F, Herbette LG, Pierce D, Scarpa A.

Biophys J. 1990 Sep;58(3):687-93.

16.

Rat cerebral cortical synaptoneurosomal membranes. Structure and interactions with imidazobenzodiazepine and 1,4-dihydropyridine calcium channel drugs.

Moring J, Shoemaker WJ, Skita V, Mason RP, Hayden HC, Salomon RM, Herbette LG.

Biophys J. 1990 Aug;58(2):513-31.

17.

Study of the topography of cannabinoids in model membranes using X-ray diffraction.

Mavromoustakos T, Yang DP, Charalambous A, Herbette LG, Makriyannis A.

Biochim Biophys Acta. 1990 May 24;1024(2):336-44.

PMID:
2162206
18.

A molecular model involving the membrane bilayer in the binding of lipid soluble drugs to their receptors in heart and brain.

Mason RP, Moring J, Herbette LG.

Int J Rad Appl Instrum B. 1990;17(1):13-33. No abstract available.

PMID:
1689708
19.

Structure of the calcium channel antagonist, nimodipine.

Wang SD, Herbette LG, Rhodes DG.

Acta Crystallogr C. 1989 Nov 15;45 ( Pt 11):1748-51.

PMID:
2610963
21.

The effects of calcium channel blocking drugs on the thermotropic behavior of dimyristoylphosphatidylcholine.

Bae SJ, Kitamura S, Herbette LG, Sturtevant JM.

Chem Phys Lipids. 1989 Jul;51(1):1-7.

PMID:
2766431
22.
24.

Orienting synthetic and native biological membranes for time-averaged and time-resolved structure determinations.

Herbette LG, Blasie JK.

Methods Enzymol. 1989;172:399-410. No abstract available.

PMID:
2747537
25.
26.
27.
28.
29.

Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers.

Chester DW, Herbette LG, Mason RP, Joslyn AF, Triggle DJ, Koppel DE.

Biophys J. 1987 Dec;52(6):1021-30.

30.

Phospholipid fatty acyl chain asymmetry in the membrane bilayer of isolated skeletal muscle sarcoplasmic reticulum.

Bick RJ, Van Winkle WB, Tate CA, Entman ML, Blasie JK, Herbette LG.

Biochemistry. 1987 Jul 28;26(15):4831-6.

PMID:
3663629
31.

X-ray diffraction analysis of cytochrome b5 reconstituted in egg phosphatidylcholine vesicles.

Rzepecki LM, Strittmatter P, Herbette LG.

Biophys J. 1986 Apr;49(4):829-38.

32.

Structural analysis of drug molecules in biological membranes.

Herbette LG, Chester DW, Rhodes DG.

Biophys J. 1986 Jan;49(1):91-4. No abstract available.

33.

Membrane damage and the pathogenesis of cardiomyopathies.

Katz AM, Freston JW, Messineo FC, Herbette LG.

J Mol Cell Cardiol. 1985 Jul;17 Suppl 2:11-20. Review.

PMID:
3897555
34.

Time-resolved x-ray diffraction studies of the sarcoplasmic reticulum membrane during active transport.

Blasie JK, Herbette LG, Pascolini D, Skita V, Pierce DH, Scarpa A.

Biophys J. 1985 Jul;48(1):9-18.

37.

Structure-function studies of canine cardiac sarcolemmal membranes. I. Estimation of receptor site densities.

Colvin RA, Ashavaid TF, Herbette LG.

Biochim Biophys Acta. 1985 Feb 14;812(3):601-8.

PMID:
2982397
38.

Mechanisms of fatty acid effects on sarcoplasmic reticulum. II. Structural changes induced by oleic and palmitic acids.

Herbette LG, Favreau C, Segalman K, Napolitano CA, Watras J.

J Biol Chem. 1984 Jan 25;259(2):1325-35.

39.

Mechanisms of fatty acid effects on sarcoplasmic reticulum. I. Calcium-fatty acid interaction.

Watras J, Messineo FC, Herbette LG.

J Biol Chem. 1984 Jan 25;259(2):1319-24.

40.

Neutron diffraction and the decomposition of membrane scattering profiles into the scattering profiles of their molecular components.

Blasie JK, Pachence JM, Herbette LG.

Basic Life Sci. 1984;27:201-10. No abstract available.

PMID:
6231916

Supplemental Content

Loading ...
Support Center